COL1A1 and metabolic dysfunction-associated steatohepatitis: After feeding mice with NASH diet for 9 weeks, targeted delivery of siTAZ to the liver can reduce the expression of inflammation and fibrosis associated marker genes, Col1a1, Col3a1 and α-SMA133.